Many commonly used drugs are typically effective in only 40-60% of the patient population, but still substantial number of subjects experience serious adverse reactions and death directly related to drug use. Personalized medicine uses genomic and molecular data to better target the delivery of healthcare by helping to determine individual patient's response to certain therapies.
Zbigniew Gaciong, Katedra i Klinika Chorob Wewnetrznych, Nadcisnienia Tetniczego i Angiologii, Warszawski Uniwersytet Medyczny, ul. Banacha 1a, Warszawa, Poland